| ALIGOS THERAPEUTICS |
| USA |
| Gesundheit |
| US01626L2043 / A40LQ4 |
| 5WK0 (Frankfurt) / ALGS (NASDAQ) |
| FRA:5WK0, ETR:5WK0, 5WK0:GR, NASDAQ:ALGS |
| - |
| https://aligos.com/ |
|
Aligos Therapeutics Inc. is a clinical-stage biote..
>Volltext.. |
| 60.16 Mio. EUR |
| -19.31 Mio. EUR |
| 2.26 Mio. EUR |
| -72.79 Mio. EUR |
| -73.7 Mio. EUR |
| -10.68 EUR |
| 5.17 Mio. EUR |
| 35.85 Mio. EUR |
| -67.48 Mio. EUR |
| 4.51 |
| -58.14% |
| -6.61% |
| - |
| - |
| - |
| - |
| ALIGOS |
| 18.12.25 |
|